SOTAC2025-04-012025-09-30SOTAC2025-09-30SOTAC2025-03-31SOTAC2025-04-012025-09-30in-capmkt:OtherExpenses1MemberSOTAC2025-04-012025-09-30RelatedPartyTransactionDomain1SOTAC2025-03-31RelatedPartyTransactionDomain1SOTAC2025-09-30RelatedPartyTransactionDomain1SOTAC2025-04-012025-09-30RelatedPartyTransactionDomain2SOTAC2025-03-31RelatedPartyTransactionDomain2SOTAC2025-09-30RelatedPartyTransactionDomain2SOTAC2025-04-012025-09-30RelatedPartyTransactionDomain3SOTAC2025-03-31RelatedPartyTransactionDomain3SOTAC2025-09-30RelatedPartyTransactionDomain3SOTAC2025-04-012025-09-30RelatedPartyTransactionDomain4SOTAC2025-03-31RelatedPartyTransactionDomain4SOTAC2025-09-30RelatedPartyTransactionDomain4SOTAC2025-04-012025-09-30RelatedPartyTransactionDomain5SOTAC2025-03-31RelatedPartyTransactionDomain5SOTAC2025-09-30RelatedPartyTransactionDomain5SOTAC2025-04-012025-09-30RelatedPartyTransactionDomain6SOTAC2025-03-31RelatedPartyTransactionDomain6SOTAC2025-09-30RelatedPartyTransactionDomain6SOTAC2025-04-012025-09-30RelatedPartyTransactionDomain7SOTAC2025-03-31RelatedPartyTransactionDomain7SOTAC2025-09-30RelatedPartyTransactionDomain7SOTAC2025-04-012025-09-30RelatedPartyTransactionDomain8SOTAC2025-03-31RelatedPartyTransactionDomain8SOTAC2025-09-30RelatedPartyTransactionDomain8SOTAC2025-04-012025-09-30RelatedPartyTransactionDomain9SOTAC2025-03-31RelatedPartyTransactionDomain9SOTAC2025-09-30RelatedPartyTransactionDomain9SOTAC2025-04-012025-09-30RelatedPartyTransactionDomain10SOTAC2025-03-31RelatedPartyTransactionDomain10SOTAC2025-09-30RelatedPartyTransactionDomain10SOTAC2025-04-012025-09-30RelatedPartyTransactionDomain11SOTAC2025-03-31RelatedPartyTransactionDomain11SOTAC2025-09-30RelatedPartyTransactionDomain11iso4217:INRiso4217:INRxbrli:shares000000SOTACNOTLISTEDINE0O2D01012Sotac Pharmaceuticals LimitedSMEEquity2025-04-012026-03-312025-11-122025-11-07INRLakhsHalf YearlyHalf yearlySingle segmentManufacturing of of a wide range of Pharmaceutical products2025-11-1216:00:002025-11-1217:00:00trueCash Flow IndirectNot applicabletruetrueNANAfalsetrue2025-05-28 https://sotacpharma.com/policies/falsefalseNA2025-04-012025-09-30UnauditedStandalone248032000109990002590310001462450007023000-66460001120200010138000121120004769700022777100031260000-22000312380000312380008394000-4780007916000233220000002332200023322000110500000102.112.11[1] The above standalone Unaudited financial results for the Half Year Ended on 30th September,'25 have been prepared by the Company in accordance with regulation 33 of SEBI <BR> (Listing Obligation & Disclosure Requirements) Regulations 2015 (as amended) and were reviewed and recommended by the Audit Committee of the Board and thereafter were <BR> approved and taken on record by the board of directors in their meeting held on 12th November, '25. <BR> [2] The standalone unaudited financial results are prepared in accordance with the Accounting Standards Prescribed urder Section 133 of the Companies Act,2013 read with Rule 7 <BR> of the Companies (Accounts) Rules, 2014 (as amended) and other recognised accounting practices and policies, as applicable <BR> [3] As per MCA Notification dated 16th February, 2015 Companies whose shares are listed on SME exchange as referred to in Chapter XB of SEBI (Issue of Capital and Disclosure <BR> Requirements) Regulation, 2009, are exempted from the compulsory requirement of adoption of IND-AS. <BR> [4] The figures for the half year ended 31st March 2025 are the Balancing figures between the audited figures in respect of full financial year and unaudited figures in respect of <BR> first half of the financial year 2024-25. <BR> [5] Previous Year's /period's figures have been regrouped/rearranged/ restated/adjusted/rectified/recasted wherever considered necessary. <BR> [6] In accordance with regulation 33 of SEBI (LODR) Regulation 2015, the above results have been reviewed by the Statutory Auditors of the Company. <BR> [7] Company is mainly engaged in manufacturing of of a wide range of pharmaceutical products such as Non Beta-Lactam (general) tablets, Non Beta-Lactam (general) capsules, <BR> Non Beta-lactam Syrup and external preparations looking into the nature of business company is operating under single segment, hence segment reporting is not applicable to <BR> [8] The Status of investor's complaints during the Half year ended on 30th September,'25 as under:- <BR> Complaints pending at the beginning of the period Nill <BR> Complaints received during the period Nill <BR> Complaints disposed during the period Nill <BR> Complaints resolved at the end of the period Nill.Other Expenses476970001105000004430340000553534000003044900000013430003179200012852700086900000324170001193170001396600012545000274355000859681000161420000015700081230001697000001222860002464000029445000001063750002313490002501000012688900098117000565231000859681000101380001211200000000-83000155000022322000-462400015460000-2906000026002000-58500017660008959000312810006251900000-1068200097490000420880000042088000000000000707500000000001068200004966000085730000085730000000423020000101380000-181000-5262100000-52621000-19600000-196000044610002501000Sotac Pharmaceuticals Limited******Sotac Healthcare Private Limited******Subsidiary CompanySale of goods or services30000000Nil757600007576000Sotac Pharmaceuticals Limited******Sotac Healthcare Private Limited******Subsidiary CompanyPurchase of goods or services15000000Nil402500004025000Sotac Pharmaceuticals Limited******Dineshkumar Babulal Gelot******Whole Time DirectorRemunerationNil9000000900000Sotac Pharmaceuticals Limited******Vishalkumar Devrajbhai Patel******Executive DirectorRemunerationNil9000000900000Sotac Pharmaceuticals Limited******Chetankumar Bachubhai Patel******Executive DirectorRemunerationNil9000000900000Sotac Pharmaceuticals Limited******Briijeshkumar Ranchhodbhai Patel******CFOAny other transactionSalaryNil4100000410000Sotac Pharmaceuticals Limited******Niyati Dipesh Parikh******Company SecretaryAny other transactionSalaryNil1200000120000Sotac Pharmaceuticals Limited******Sotac Lifescienes Private Limited******Subsidiary CompanyInterest paidNil40000001200000004000000Sotac Pharmaceuticals Limited******Sotac Lifescienes Private Limited******Subsidiary CompanyInterest receivedNil93230001200000009323000Sotac Pharmaceuticals Limited******Sotac Research Private Limited******Wholly owned subsidiary companyPurchase of goods or services1000000Nil2500001751000250000Sotac Pharmaceuticals Limited******Sharadkumar Dashrathbhai Patel******Managing DirectorRemunerationNil900000090000029304000